Ultrashort Nasdaq Biotech Proshares (BIS) 26.30

New Post Public Reply Private Reply Replies (0) Message Board

Jul 28, 2015 at 1:52 PM

Ultrashort Nasdaq Biotech Proshares (BIS) 26.30 $BIS

What The ECB Will Do
Chuck Butler - Daily Reckoning - Tue Jun 30, 9:35AM CDT
This post What The ECB Will Do appeared first on Daily Reckoning . Chuck Butler explains the breakdown of the Greek referendum vote that will take place this Sunday, plus the euro rallies then sells off, and another week data print from New...
BIS: 26.30 (-1.30)

Two more triple-levered biotech ETFs launch
Seeking Alpha - at Seeking Alpha - Tue Jun 23, 8:22AM CDT

BBP: 36.45 (+0.97), PBE: 60.14 (+1.62), BBC: 36.90 (+0.72), SBIO: 38.68 (+1.06), BIS: 26.30 (-1.30), HQL: 29.30 (+1.25), FBT: 126.66 (+2.81), BIB: 96.49 (+4.34), XBI: 259.13 (+7.35), BBH: 139.00 (+2.99), IBB: 382.51 (+8.93), LABU: 50.30 (+4.07), LABD: 27.71 (-2.66)

Biotech Bio-Hazard
James Stefurak, CFA - at Seeking Alpha - Tue Jun 16, 10:58AM CDT

BIIB: 315.85 (+6.42), BIS: 26.30 (-1.30), GILD: 113.08 (+2.54), IBB: 382.51 (+8.93), AMGN: 172.81 (+7.27), AAPL: 123.31 (+0.54), CELG: 135.72 (+3.16)

Why I'm Shorting Biotech
George Budwell, The Motley Fool - Motley Fool - Sat Jun 13, 12:16PM CDT
Biotech and biopharma have had an incredible run over the past few years. And like many investors, I've been able to crush the broader markets simply by buying and holding top names in the industry like AbbVie , Gilead Sciences , and Isis...
ESRX: 91.55 (+0.45), BIS: 26.30 (-1.30), ISIS: 54.60 (+0.92), GILD: 113.08 (+2.54), MRK: 57.42 (+0.43), IBB: 382.51 (+8.93), ABBV: 70.71 (+1.37), BMY: 64.45 (+0.15), CELG: 135.72 (+3.16)

Intro Guide to Leveraged Biotech ETF Investing - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Tue Jun 09, 11:08AM CDT
A quick discussion of the ways investors can play the biotechnology sector with leverage.
BIS: 26.30 (-1.30), BIB: 96.49 (+4.34), LABU: 50.30 (+4.07), LABD: 27.71 (-2.66)

When Genius Fails Again, Part I
Addison Wiggin - Daily Reckoning - Fri May 22, 3:06PM CDT
This post When Genius Fails Again, Part I appeared first on Daily Reckoning . Addison takes a look behind the curtain during a seminal moment in The Daily Reckoning’s history… The post When Genius Fails Again, Part I appeared first on Daily...
BIS: 26.30 (-1.30)

Hidden Gems In This Market Cycle's Leading Theme
Cam Hui, CFA - Seeking Alpha - Fri May 08, 5:18AM CDT
Philosophical Economics wrote a terrific post yesterday about how the "Winner take all" economy is affecting companies and the competitive environment. He observed that net margins have been elevated in the last few years. Generally, when...
BIS: 26.30 (-1.30), BIB: 96.49 (+4.34), IBB: 382.51 (+8.93)

FDA to hold public meeting on off-label drug promotion
Seeking Alpha - at Seeking Alpha - Thu May 07, 10:13AM CDT

ABT: 50.96 (+0.27), BIB: 96.49 (+4.34), PFE: 35.10 (+0.76), IBB: 382.51 (+8.93), DRGS: 60.10 (-0.69), LLY: 85.56 (+1.41), BMY: 64.45 (+0.15), GSK: 41.64 (+0.04), JNJ: 98.90 (+0.62), BIS: 26.30 (-1.30), AZN: 32.87 (+0.16), MRK: 57.42 (+0.43), ABBV: 70.71 (+1.37), SNY: 53.67 (+0.34), IRY: 54.12 (+0.52), IXJ: 111.78 (+1.48), NVS: 102.59 (+1.05)

Biotechs continue slide
Seeking Alpha - at Seeking Alpha - Wed Apr 29, 11:42AM CDT

BIS: 26.30 (-1.30), BIB: 96.49 (+4.34), IBB: 382.51 (+8.93)

Drug makers getting visability over aggressive pricing practices
Seeking Alpha - at Seeking Alpha - Mon Apr 27, 10:19AM CDT

MNK: 122.87 (-0.21), BIS: 26.30 (-1.30), VRX: 257.73 (+0.43), BIB: 96.49 (+4.34), IBB: 382.51 (+8.93), DRGS: 60.10 (-0.69)

U.S. drug spending rose 13% in 2014
Seeking Alpha - at Seeking Alpha - Tue Apr 14, 6:28AM CDT

BIS: 26.30 (-1.30), BIB: 96.49 (+4.34), IBB: 382.51 (+8.93), DRGS: 60.10 (-0.69), IXJ: 111.78 (+1.48), IRY: 54.12 (+0.52)

Infographic: Developing Economies Graying Faster
The Financialist - at Seeking Alpha - Thu Apr 09, 4:38PM CDT
(click to enlarge) Original post Read comments Read more articles from Seeking Alpha: Our Second Best Performing Stock For First Quarter 2015 - Maiden Holdings, Ltd. Rich Middle Class, Poor Middle Class Why Investors Shouldn't...
BIS: 26.30 (-1.30), BIB: 96.49 (+4.34), IBB: 382.51 (+8.93), DRGS: 60.10 (-0.69), IXJ: 111.78 (+1.48), IRY: 54.12 (+0.52)

BUYINS.NET: BIS, Has Remained On Naked Short Lists 13 Consecutive Days
M2 - Tue Mar 31, 4:21AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Has Remained On the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
BIS: 26.30 (-1.30)

BIS vs. IBB is The 'Chart of the Day'
at The Street - Thu Mar 26, 9:14AM CDT
The BIS vs. IBB is the OptionsProfits 'Chart of the Day.'
BIS: 26.30 (-1.30), IBB: 382.51 (+8.93)

Biotechs selling off on increased volume
Seeking Alpha - at Seeking Alpha - Wed Mar 25, 11:13AM CDT

BIS: 26.30 (-1.30), BIB: 96.49 (+4.34), IBB: 382.51 (+8.93)

FDA to assess homeopathy business
Seeking Alpha - at Seeking Alpha - Tue Mar 24, 3:42PM CDT

BIS: 26.30 (-1.30), BIB: 96.49 (+4.34), IBB: 382.51 (+8.93), DRGS: 60.10 (-0.69), IXJ: 111.78 (+1.48), IRY: 54.12 (+0.52)

2015-0319 - Index - CSE Composite Index Quarterly Rebalancing
Marketwire Canada - Thu Mar 19, 3:06PM CDT
The quarterly rebalancing of the CSE Composite Index will result in the following changes, effective after the close on Friday, March 20, 2015.
SEE: 49.90 (+0.39), GFI: 2.80 (-0.08), BIS: 26.30 (-1.30), ACH: 8.98 (+0.12), BOI: 15.26 (+0.06)

Pharma and Biotech M&A deals reached $212B last year
Seeking Alpha - at Seeking Alpha - Thu Mar 19, 10:45AM CDT

BIS: 26.30 (-1.30), BIB: 96.49 (+4.34), IBB: 382.51 (+8.93), DRGS: 60.10 (-0.69), IXJ: 111.78 (+1.48), IRY: 54.12 (+0.52)

BlackIce Enterprise Sponsors Vietnam Seminar on Basel II Implementation
ACCESSWIRE - Tue Jan 13, 4:02PM CST
Vancouver, BC / ACCESSWIRE / January 13, 2015 / BlackIce Enterprise Risk Management Inc. (BlackIce) (CSE: BIS), along with IBM, is a co-sponsor of the 'Leverage ICAAP for Basel II Implementation' seminar to be held in Hanoi, Vietnam on Thursday January 15, 2015.
BIS: 26.30 (-1.30), IBM: 159.49 (+0.42)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IWP and VYRE Unveil 'The Plug' for VBNGtv Content

Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...

NYSE Texas Redefines the U.S. Capital Markets Landscape

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Charter Next Generation Unveils Gen 2 MDO-PE Films

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Skandia's Soundproofing Kit Expands to Brazil's Skies

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Truss Financial Tackles Home Equity Closing Delays

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Cure Blindness Project's 770K Screenings for World Sight Day

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Navigating Holiday Sweets: Healthy Balancing Acts

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

JiMMYBAR! Expands Creatine Market with Target Launch

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Karoo Health Leaps Forward with New CCO Breton

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...